Home » Northwest Receives US Patent for Automation of DCVax Manufacturing
Northwest Receives US Patent for Automation of DCVax Manufacturing
Northwest Biotherapeutics, Inc. announced Friday that the US
Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company’s
DCVax therapeutic cancer vaccines.
Yahoo!
Yahoo!
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May